ARID1A and colorectal carcinoma: These results were consistent with our previous observations that ARID1A- CRC cell lines are more sensitive to ATR inhibitors and indicated that the radiosensitizing effect after ATRi treatment mainly relied on the ARID1A status of the cell lines.